Han will work with the C-suite on delivering sound accounting practices, growing the team and keeping the firm compliant with regulations
() (OTCMKTS:AUSAF) said Tuesday that it has strengthened the company’s leadership team by promoting Alex Han, who was vice president of accounting, to the role of chief accounting officer.
In a statement, Australis Capital CEO Scott Dowty said Han is an “exceptional executive” who has proven her unique skills during the past year and brought “tremendous value” to the company.
"As Australis Capital evolves, Alex will work closely with the C-suite and board of directors delivering on sound accounting practices, regulatory compliance, and strategic planning while expanding her highly skilled team," said Dowty.
READ: Australis Capital merging with Folium Biosciences to create vertically integrated producer of CBD
In 2018, Han joined Australis Capital with over 15 years of experience in public and corporate accounting, with expertise in financial accounting, international accounting, and internal controls. Han has held several finance and accounting management positions in multi-billion-dollar global companies.
She began her career in accounting as an auditor at Ernst & Young, LLP. Han holds a Master of Science degree in Accountancy from the University of Nevada, Las Vegas and is a certified global management accountant and certified public accountant licensed in Nevada.
"I am honored to become chief accounting officer at such an important and exciting time for the company," said Han. “I am committed to working alongside the leadership team to contribute to the company's future growth and continued success while building a collaborative, engaged, and fun company culture."
Australis Capital aims to build companies through early-stage, opportunistic, and diversified investments in the cannabis value chain in the US and abroad. Australis was spun out from cannabis behemoth Aurora Cannabis Inc (TSE:ACB) (NYSE:ACB) in September 2018 as its US investment vehicle.
Colorado Springs-based Folium Biosciences, a vertically integrated B2B producer and manufacturer, is a wholly-owned subsidiary of Australis.
Contact the author Uttara Choudhury at [email protected]
Follow her on Twitter: @UttaraProactive